Latest Articles

Publication Date
Pioneering robotic surgery for complex gynecologic conditions: implementation beyond cancer care.

Minimally invasive surgery was introduced to minimize some of the issues associated with open surgery. Its benefits include fewer complications, less pain and blood loss, shorter hospital stays, quicker recovery, …

Published: Sept. 23, 2025, midnight
Perioperative Anesthetic and Hormonal Considerations in a Patient With Anti-glutamic Acid Decarboxylase Encephalitis: A Case Report.

Glutamic acid decarboxylase (GAD) is vital for gamma-aminobutyric acid (GABA) synthesis. Auto-antibodies against GAD deplete GAD levels and subsequently GABA, resulting in a hyper-excitatory state. A 41-year-old woman with anti-GAD …

Published: Sept. 22, 2025, midnight
Genmab takes its Profound buy into endometrial | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Genmab takes its Profound buy into endometrial | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: Sept. 16, 2025, 3:39 p.m.
Panel Discussion on Endometrial Cancer Challenges and Advances – FDA Oncology - Oncodaily

Panel Discussion on Endometrial Cancer Challenges and Advances – FDA Oncology Oncodaily

Published: Sept. 14, 2025, 7:31 p.m.
Rx Road Map: Durvalumab for Endometrial Cancer - Oncology Nursing News

Rx Road Map: Durvalumab for Endometrial Cancer Oncology Nursing News

Published: Sept. 11, 2025, 6:21 p.m.
GSK enters Indian oncology market with gynaecological cancer drugs - MSN

GSK enters Indian oncology market with gynaecological cancer drugs MSN

Published: Aug. 28, 2025, 8:16 a.m.
FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer - Targeted Oncology

FDA Breakthrough Therapy Granted for Novel ADC in Endometrial Cancer Targeted Oncology

Published: Aug. 26, 2025, 6:30 p.m.
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer - Oncology Nursing News

Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer Oncology Nursing News

Published: Aug. 26, 2025, 6:04 p.m.
Genmab's Rina-S: A Breakthrough in Gynecologic Oncology and a Catalyst for Value Creation - AInvest

Genmab's Rina-S: A Breakthrough in Gynecologic Oncology and a Catalyst for Value Creation AInvest

Published: Aug. 26, 2025, 1:01 p.m.
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? - MSN

Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? MSN

Published: Aug. 26, 2025, 12:50 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!